MTOR and cancer: Serine/threonine kinase Akt (protein kinase B) plays an important role in the PI3K/Akt/mTOR pathway, and abnormally activated Akt is commonly seen in cancer [2, 5], including metastatic castration-resistant prostate cancer (mCRPC) [6, 7].